ONO PHARMACEUTICAL CO.,LTD. [4528.T]

TOKYO, May 08 (Pulse News Wire) – Ono Pharmaceutical Co., Ltd. (4528.T) reported consolidated results for fiscal year 2026 ending March.

Revenue was ¥520 billion (+5.9% YoY). operating profit was ¥92,236 million (+54.4%).

Net profit attributable to shareholders was ¥69,911 million (+39.4%). The company declared an annual dividend of ¥40 per share.

Financial results — FY2026/3 (consolidated)

MetricCurrentYoY
Revenue¥515,785M+5.9%
Operating profit¥92,236M+54.4%
Net profit¥69,911M+39.4%

Source: TDNet filing · Figures in millions of yen

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.